Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00060411
Status:
COMPLETED
Last Update Posted:
2013-09-30
First Post:
2003-05-06
Brief Title:
A Phase I Pharmacological and Biological Study of OSI-774 in Combination With FOLFOX 4 5-FU Leucovorin and Oxaliplatin and Bevacizumab Avastin in Patients With Advanced Colorectal Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IVB Rectal Cancer |
| Mucinous Adenocarcinoma of the Colon |
| Mucinous Adenocarcinoma of the Rectum |
| Recurrent Colon Cancer |
| Recurrent Rectal Cancer |
| Signet Ring Adenocarcinoma of the Colon |
| Signet Ring Adenocarcinoma of the Rectum |
| Stage IIIA Colon Cancer |
| Stage IIIA Rectal Cancer |
| Stage IIIB Colon Cancer |
| Stage IIIB Rectal Cancer |
| Stage IIIC Colon Cancer |
| Stage IIIC Rectal Cancer |
| Stage IVA Colon Cancer |
| Stage IVA Rectal Cancer |
| Stage IVB Colon Cancer |
Keywords: